NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Check the time stamp on this data. Updated AI-Generated Signals for Transmedics Group Inc. (TMDX) available here: TMDX. Type ...
TransMedics Group Inc (TMDX) stock saw a modest uptick, ending the day at $67.03 which represents a slight increase of $5.96 or 9.76% from the prior close of $61.07. The stock opened at $61.47 and ...
New York, New York-- (Newsfile Corp. - January 29, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion Capital on Jan. 10, 2025, stating them as inaccurate and misleading.
Headwaters Capital Management highlighted stocks like TransMedics Group, Inc. (NASDAQ:TMDX) in the Q4 2024 investor letter. TransMedics Group, Inc. (NASDAQ:TMDX) is a commercial-stage medical ...